Highly sensitive detection and localization of maternally acquired human cytomegalovirus in placental tissue by in situ polymerase chain reaction

Journal of Infectious Diseases

Volumn 192, Issue 4, 2005, Pages 650-657

  Trincado, Daniel E ^a,b   Munro, Sian C ^a,b,c   Camaris, Catherine ^a   Rawlinson, William D ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B; RNA; VIRUS DNA;

ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; FETUS; FETUS CIRCULATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PLACENTA; PLACENTA VILLUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIRD TRIMESTER PREGNANCY; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TROPHOBLAST; UL21.5 VIRION GENE; VIRION; VIRUS DETECTION; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION;

CYTOMEGALOVIRUS; DNA, VIRAL; FEMALE; GENES, IMMEDIATE-EARLY; GENOTYPE; HUMANS; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY; RNA, VIRAL; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

EID: 23244456656     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/431999     Document Type: Article

References (44)

1. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-8.
2. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002; 57:245-56.
3. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104:55-60.
4. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344:1366-71.
5. Li W, Anwar F, Jesurrun J, Erice A. Cytomegalovirus UL97 and glycoprotein B (gB) sequences in tissues from immunocompromised patients with ganciclovir-resistant virus infection. Scand J Infect Dis 1999; 31:549-53.
6. Bale JF Jr, Murph JR, Demmler GJ, Dawson J, Miller JE, Petheram SJ. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000; 182:933-6.
7. Trincado DE, Scott GM, White PA, Hunt C, Rasmussen L, Rawlinson WD. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 2000; 61:481-7.
8. Arav-Boger R, Willoughby RE, Pass RF, et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-α and β-chemokine receptors in congenital CMV disease. J Infect Dis 2002; 186:1057-64.
9. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680-715.
10. Lazzarotto T, Gabrielli L, Foschini MP, et al. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003;112:e153-7.
11. Kumar ML, Prokay SL. Experimental primary cytomegalovirus infection in pregnancy: timing and fetal outcome. Am J Obstet Gynecol 1983; 145:56-60.
12. Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 1999; 93:658-60.
13. Benirschke K. Remarkable placenta. Clin Anat 1998; 11:194-205.
14. Gerna G, Zipeto D, Percivalle E, et al. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J Infect Dis 1992; 166:1236-44.
15. Saetta A, Agapitos E, Davaris PS. Determination of CMV placentitis: diagnostic application of the polymerase chain reaction. Virchows Arch 1998; 432:159-62.
16. Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000; 74:6808-20.
17. Gabrielli L, Losi L, Varani S, Lazzarotto T, Eusebi V, Landini MP. Complete replication of human cytomegalovirus in expiants of first trimester human placenta. J Med Virol 2001; 64:499-504.
18. Maidji E, Percivalle E, Gerna G, Fisher S, Pereira L. Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts. Virology 2002; 304:53-69.
19. Griffith BP, McCormick SR, Fong CK, Lavallee JT, Lucia HL, Goff E. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 1985; 55:402-9.
20. Chatterjee A, Harrison CJ, Britt WJ, Bewtra C. Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein B antibody transfer in guinea pigs. J Infect Dis 2001; 183:1547-53.
21. Mocarski ES Jr, Kemble GW. Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 1996; 39:320-30.
22. Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 1996; 70:8833-49.
23. Mocarski ES, Bonyhadi M, Salimi S, McCune JM, Kaneshima H. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication. Proc Natl Acad Sci USA 1993; 90:104-8.
24. Muhlemann K, Miller RK, Metlay L, Menegus MA. Cytomegalovirus infection of the human placenta: an immunocytochemical study. Hum Pathol 1992; 23:1234-7.
25. Sinzger C, Muntefering H, Loning T, Stoss H, Plachter B, Jahn G. Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining. Virchows Arch A Pathol Anat Histopathol 1993; 423:249-56.
26. Muhlemann K, Menegus MA, Miller RK. Cytomegalovirus in the perfused human term placenta in vitro. Placenta 1995; 16:367-73.
27. Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis J, Guilbert LJ. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 1998; 72:4970-9.
28. Nuovo GJ. In situ localization of PCR-amplified DNA and cDNA. Methods Mol Biol 2000; 123:217-38.
29. Rasmussen L, Hong C, Zipeto D, et al. Cytomegalovirus gB genotype distribution differs in human immunodeficiency virus-infected patients and immunocompromised allograft recipients. J Infect Dis 1997; 175:179-84.
30. Scott GM, Barrell BG, Oram J, Rawlinson WD. Characterisation of transcripts from the human cytomegalovirus genes TRL7, UL20a, UL36, UL65, UL94, US3 and US34. Virus Genes 2002; 24:39-48.
31. Halwachs-Baumann G, Wilders-Truschnig M, Enzinger G, et al. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays. J Clin Virol 2001; 20:49-57.
32. Long AA, Komminoth P. In situ PCR: an overview. Methods Mol Biol 1997; 71:141-61.
33. Sinzger C, Jahn G. Human cytomegalovirus cell tropism and pathogenesis. Intervirology 1996; 39:302-19.
34. Schafer P, Tenschert W, Cremaschi L, Schroter M, Gutensohn K, Laufs R. Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients. J Med Virol 2000; 61:488-96.
35. Furukawa T, Jisaki F, Sakamuro D, Takegami T, Murayama T. Detection of human cytomegalovirus genome in uterus tissue. Arch Virol 1994; 135:265-77.
36. King A, Thomas L, Bischof P. Cell culture models of trophoblast II: trophoblast cell lines-a workshop report. Placenta 2000; 21 (Suppl A): S113-9.
37. Kristoffersen EK, Matre R. Surface annexin II on placental membranes of the fetomaternal interface. Am J Reprod Immunol 1996; 36:141-9.
38. Wright JF, Kurosky A, Pryzdial EL, Wasi S. Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol 1995; 69:4784-91.
39. Raynor CM, Wright JF, Waisman DM, Pryzdial EL. Annexin II enhances cytomegalovirus binding and fusion to phospholipid membranes. Biochemistry 1999; 38:5089-95.
40. Compton T. Receptors and immune sensors: the complex entry path of human cytomegalovirus. Trends Cell Biol 2004; 14:5-8.
41. Halwachs-Baumann G, Wilders-Truschnig M, Desoye G, et al. Human trophoblast cells are permissive to the complete replicative cycle of human cytomegalovirus. J Virol 1998; 72:7598-602.
42. Gerna G, Percivalle E, Baldanti F, Revello MG. Lack of transmission to polymorphonuclear leukocytes and human umbilical vein endothelial cells as a marker of attenuation of human cytomegalovirus. J Med Virol 2002; 66:335-9.
43. Meyer-Konig U, Vogelberg C, Bongarts A, et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998; 55:75-81.
44. Munro SC, Hall B, Waliuzzaman Z, et al. Detection and transmission of congenital CMV [abstract 10.31]. In: Program and abstracts of the 29th annual International Herpesvirus Workshop (Reno, Nevada). Reno: University of Nevada, 2004.